|
1 Company |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
1 Trial |
|
5 News |
|
- Ventolin (albuterol) / GSK
Phase classification: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes (clinicaltrials.gov) - Oct 17, 2014
P1, N=21, Completed, Sponsor: Mayo Clinic
Phase classification: P=N/A --> P1
- Ventolin (albuterol) / GSK
Enrollment change: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes (clinicaltrials.gov) - Jan 7, 2014
P=N/A, N=21, Completed, Sponsor: Mayo Clinic
Phase classification: P=N/A --> P1 N=50 --> 21
- | Ventolin (albuterol) / GSK
Trial completion: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes (clinicaltrials.gov) - Jan 7, 2014
P=N/A, N=21, Completed, Sponsor: Mayo Clinic
N=50 --> 21 Recruiting --> Completed